Timothy Spong, Co-Founder and CEO of Vistapath (Modernizing Pathology Labs with AI)

Taking Notes with NextGen

In this episode of Taking Notes with NextGen, our host Chris Keller (Managing Partner at NextGen) interviews Timothy Spong, Co-Founder and CEO of Vistapath Biosystems (Vistapath), where NextGen Venture Partners is a proud investor. Vistapath is a digital health company with a mission to modernize pathology labs to increase the quality of patient care. Tim and Chris talk about what inspired Tim to start the company, how the company is improving labs today, and what he is most excited about for the future. Disclaimers: The information contained in this podcast is for informational purposes only, and is not an offer to sell, or a solicitation of an offer to purchase any securities. Past performance is not indicative of future results. Any performance or projections contained herein may be significantly affected by future events. Any opinions, assumptions, assessments, statements or the like regarding future events, or which are forward looking constitute only subjective views and beliefs should not be relied on and are subject to change due to a variety of factors including fluctuating market conditions and economic factors.